In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Genitope Corp.

Latest From Genitope Corp.

Thomas DeZao heads commercial ops at Talon

Talon Therapeutics has appointed Thomas DeZao head of commercial operations and planning function, ahead of Marqibo's (vincristine sulphate liposomes injection) 12 August PDUFA date. Mr DeZao's experience includes senior commercial and marketing positions related to hematologic cancer product candidates at ChemGenex Pharmaceuticals, Genitope Corporation and Corixa/Coulter Pharmaceuticals.


Pharmacyclics clinches $150 million up front from Janssen in blood cancer deal

Pharmacyclics has received $150 million up front under a development and commercialisation deal with Johnson & Johnson unit Janssen Biotech for a first-in-class oral candidate for haematological malignancies currently in Phase II trials.

Cancer Orthopedics

Personalised therapeutic cancer vaccine shows benefit in Phase III lymphoma trial

Biovest International's (Accentia Biopharmaceuticals) therapeutic cancer vaccine BiovaxID looks to have become the first to improve disease-free survival (DFS) in follicular lymphoma (FL) in the pivotal Phase III BV-301 study that was highlighted at a plenary session at the ASCO meeting in Orlando.

Cancer Clinical Trials

Executive Briefing - The biotech company league table

The world's first biotechnology company, Genentech, was founded in 1976. 30 years later there were 4,275 biotechnology companies worldwide, of which 710 were publicly listed. Dr Peter Charlish reviews the fortunes of the top 100 biotech companies involved in human healthcare on the basis of product sales and R&D investment

Gastrointestinal Metabolic Disorders
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Genitope Corp.
  • Senior Management
  • Dan W Denney, Jr., PhD, CEO & Interim CFO
    Tom DeZao, VP, Strategic Mktg. & Sales
    Thomas P Theriault, PhD, VP, R&D
  • Contact Info
  • Genitope Corp.
    Phone: (510) 284-3000
    6900 Dumbarton Cr.
    Freemont, CA 94555